TrialPanorama/TrialPanorama-database huggingface dataset:
Study 29722627 — Surrogate Endpoint (SUR): Blood pressure
Study 19317161 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 9952267 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 6407052 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study 27103201 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 24509716 — Surrogate Endpoint (SUR): Pathological complete response
Study 30428398 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 30428398 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 25165161 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 22130166 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 22130166 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22130166 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 27330977 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 30169539 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 23130488 — Surrogate Endpoint (SUR): Blood pressure
Study 18577730 — Surrogate Endpoint (SUR): Blood pressure
Study 10634670 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21119532 — Surrogate Endpoint (SUR): Serum creatinine
Study 21119532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16507428 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16507428 — Surrogate Endpoint (SUR): Blood pressure
Study 19637098 — Predictive Biomarker (PRD): P2RY12 mRNA
Genes: P2RY12; HORK3
Study 19637098 — Predictive Biomarker (PRD): P2RY1 mRNA
Genes: P2RY1
Study 19637098 — Predictive Biomarker (PRD): ITGB3 mRNA
Genes: ITGB3; GP3A
Study 16684825 — Surrogate Endpoint (SUR): Bone mineral density
Study 27789136 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25486494 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21515999 — Surrogate Endpoint (SUR): Blood pressure
Study 23360079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23360079 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 23360079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 23360079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23360079 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 11408508 — Surrogate Endpoint (SUR): Bone mineral density
Study 26229448 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 22114896 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 18772602 — Surrogate Endpoint (SUR): Blood pressure
Study 8849376 — Safety Biomarker (SAF): Interleukin 1
Study 10972598 — Surrogate Endpoint (SUR): Blood pressure
Study 6531024 — Predictive Biomarker (PRD): EMP1 mRNA
Genes: EMP1; B4B; TMP
Study 25194966 — Surrogate Endpoint (SUR): Serum triglycerides
Study 25194966 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18679600 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 18679600 — Surrogate Endpoint (SUR): Serum creatinine
Study 16003661 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 30326551 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 28654958 — Predictive Biomarker (PRD): RDH5 mRNA
Genes: RDH5; HSD17B9; RDH1; SDR9C5
Study 28654958 — Predictive Biomarker (PRD): PPOX mRNA
Genes: PPOX
Study 25362844 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 25362844 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 25362844 — Predictive Biomarker (PRD): TMEM37 mRNA
Genes: TMEM37; PR
Study 23040208 — Surrogate Endpoint (SUR): Bone mineral density
Study 8682921 — Surrogate Endpoint (SUR): Bacterial count
Study 28050798 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 22495466 — Surrogate Endpoint (SUR): Blood pressure
Study 8942009 — Surrogate Endpoint (SUR): Forced vital capacity
Study 906784 — Surrogate Endpoint (SUR): Serum potassium
Study 31768936 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 26124203 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26124203 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21630245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10215942 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2696433 — Safety Biomarker (SAF): Lactotransferrin
Genes: LTF; GIG12; LF
Study 16632 — Surrogate Endpoint (SUR): Blood pressure
Study 24751502 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 20233178 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 20233178 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 15607868 — Surrogate Endpoint (SUR): Bone mineral density
Study 12107600 — Surrogate Endpoint (SUR): Blood pressure
Study 20024680 — Surrogate Endpoint (SUR): Blood pressure
Study 17219991 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 17219991 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 1574257 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29234869 — Surrogate Endpoint (SUR): Blood pressure
Study 22019270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22019270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22019270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21313927 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16261288 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 16261288 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 28199679 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25733243 — Surrogate Endpoint (SUR): Blood pressure
Study 21165798 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 7690225 — Surrogate Endpoint (SUR): Blood pressure
Study 25999694 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 3284690 — Surrogate Endpoint (SUR): Blood pressure
Study 29611086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29611086 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 29611086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29611086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25204719 — Surrogate Endpoint (SUR): Blood pressure
Study 25204719 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31047803 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31047803 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 27364549 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25176085 — Surrogate Endpoint (SUR): Blood pressure
Study 7118361 — Surrogate Endpoint (SUR): Blood pressure
Study 31111884 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 28079136 — Predictive Biomarker (PRD): RXRA mRNA
Genes: RXRA; NR2B1
Study 28079136 — Predictive Biomarker (PRD): CYP2R1 mRNA
Genes: CYP2R1
Study 28079136 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 19786658 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 19786658 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19786658 — Predictive Biomarker (PRD): Hormone receptor
Study 15550024 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15550024 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 15550024 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 6143666 — Surrogate Endpoint (SUR): Blood pressure
Study 30661699 — Predictive Biomarker (PRD): COG2 mRNA
Genes: COG2; LDLC
Study 18000087 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 18000087 — Safety Biomarker (SAF): Cytochrome c
Study 10405943 — Surrogate Endpoint (SUR): Bone mineral density
Study 1877455 — Surrogate Endpoint (SUR): Blood pressure
Study 29924746 — Surrogate Endpoint (SUR): Bone mineral density
Study 25092781 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 23884390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23884390 — Surrogate Endpoint (SUR): Blood pressure
Study 18699936 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 12953133 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12953133 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 6386275 — Surrogate Endpoint (SUR): Blood pressure
Study 21805305 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 19851298 — Surrogate Endpoint (SUR): Blood pressure
Study 1964663 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 1964663 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 12955426 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 10871828 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 2428266 — Surrogate Endpoint (SUR): Blood pressure
Study 2428266 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 2428266 — Surrogate Endpoint (SUR): Serum creatinine
Study 7515706 — Surrogate Endpoint (SUR): Serum potassium
Study 27552564 — Surrogate Endpoint (SUR): Blood pressure
Study 27552564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 1569294 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31634003 — Safety Biomarker (SAF): Hyaluronic acid
Study 26829000 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24828079 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 20585110 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11472706 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18520295 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 18520295 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 12639245 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12639245 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 27852695 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 27852695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23422107 — Surrogate Endpoint (SUR): Bone mineral density
Study 19761938 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 17702701 — Surrogate Endpoint (SUR): Forced vital capacity
Study 14749206 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 14749206 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study 14749206 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 25880826 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study 31253216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31253216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11382625 — Surrogate Endpoint (SUR): Blood pressure
Study 9402180 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 8218536 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 29996886 — Surrogate Endpoint (SUR): Blood pressure
Study 21432590 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 19720587 — Surrogate Endpoint (SUR): Bone mineral density
Study 1670586 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1670586 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 4072925 — Surrogate Endpoint (SUR): Blood pressure
Study 17674020 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 17954055 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 17954055 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10904462 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10904462 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10904462 — Surrogate Endpoint (SUR): Blood pressure
Study 28419997 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 28419997 — Predictive Biomarker (PRD): GCKR mRNA
Genes: GCKR
Study 28419997 — Predictive Biomarker (PRD): CCNL1 mRNA
Genes: CCNL1; BM-001; UNQ530/PRO1073
Study 28419997 — Predictive Biomarker (PRD): COBLL1 mRNA
Genes: COBLL1; KIAA0977
Study 28419997 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study 21444869 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 21444869 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 11062357 — Surrogate Endpoint (SUR): Bone mineral density
Study 3758170 — Surrogate Endpoint (SUR): Blood pressure
Study 28397581 — Surrogate Endpoint (SUR): Bone mineral density
Study 27072372 — Surrogate Endpoint (SUR): Serum triglycerides
Study 22895063 — Surrogate Endpoint (SUR): Blood pressure
Study 22895063 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12505235 — Surrogate Endpoint (SUR): Blood pressure
Study 10767520 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 25952589 — Predictive Biomarker (PRD): KCNK3 mRNA
Genes: KCNK3; TASK; TASK1
Study 25322847 — Surrogate Endpoint (SUR): Blood pressure
Study 2493413 — Surrogate Endpoint (SUR): Blood pressure
Study 23980355 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 23980355 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15798812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15798812 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9815743 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 22027191 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 22027191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31778599 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 31778599 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 21044870 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 21044870 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21044870 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 19816079 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 8822914 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 17911178 — Surrogate Endpoint (SUR): Bone mineral density
Study 17911178 — Surrogate Endpoint (SUR): Serum calcium
Study 11874742 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study 11874742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 20335158 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8613013 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 17041858 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10654902 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study 10654902 — Surrogate Endpoint (SUR): Serum testosterone
Study 29943430 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 10362732 — Surrogate Endpoint (SUR): Blood pressure
Study 8895035 — Surrogate Endpoint (SUR): Blood pressure
Study 6661351 — Surrogate Endpoint (SUR): Blood pressure
Study 6661351 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 27411361 — Surrogate Endpoint (SUR): Blood pressure
Study 19200365 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 17095923 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 28266765 — Predictive Biomarker (PRD): RNF43 mRNA
Genes: RNF43
Study 28266765 — Predictive Biomarker (PRD): TOMM34 mRNA
Genes: TOMM34; URCC3
Study 28266765 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 14678271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7774069 — Surrogate Endpoint (SUR): Serum creatinine
Study 31411968 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30696178 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study 14752416 — Surrogate Endpoint (SUR): Blood pressure
Study 3581696 — Safety Biomarker (SAF): 51Cr-EDTA
Study 3581696 — Surrogate Endpoint (SUR): Serum creatinine
Study 26652606 — Surrogate Endpoint (SUR): Blood pressure
Study 18672299 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8833493 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 15676045 — Safety Biomarker (SAF): Hyaluronic acid
Study 29956424 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 21362526 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 8807172 — Surrogate Endpoint (SUR): Blood pressure
Study 1533767 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 1533767 — Surrogate Endpoint (SUR): Blood pressure
Study 1533767 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 30141289 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30141289 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30141289 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30141289 — Surrogate Endpoint (SUR): Serum creatinine
Study 24501094 — Predictive Biomarker (PRD): DUSP2 mRNA
Genes: DUSP2; PAC1
Study 14620915 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 29031771 — Surrogate Endpoint (SUR): Blood pressure
Study 27007018 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19858141 — Surrogate Endpoint (SUR): Blood pressure
Study 14653123 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 14653123 — Surrogate Endpoint (SUR): Blood pressure
Study 2949396 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 31712838 — Predictive Biomarker (PRD): LHB mRNA
Genes: LHB
Study 30226342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17233236 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 7889194 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7889194 — Surrogate Endpoint (SUR): Blood pressure
Study 2663263 — Surrogate Endpoint (SUR): Blood pressure
Study 4612057 — Surrogate Endpoint (SUR): Blood pressure
Study 18272539 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 7032826 — Surrogate Endpoint (SUR): Blood pressure
Study 7032826 — Surrogate Endpoint (SUR): Serum potassium
Study 31488369 — Surrogate Endpoint (SUR): Blood pressure
Study 25450709 — Monitoring Biomarker (MOI): HBV DNA
Study 25420474 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 21763935 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7686707 — Surrogate Endpoint (SUR): Blood pressure
Study 26228675 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18285392 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8572358 — Surrogate Endpoint (SUR): Blood pressure
Study 17050563 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 9802119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9802119 — Safety Biomarker (SAF): Interleukin 1
Study 9802119 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 9802119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9802119 — Predictive Biomarker (PRD); Safety Biomarker (SAF): IL1B
Genes: IL1F2; IL-1B; IL1-BETA
Study 2506671 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 26461996 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 21396086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 18285604 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 1694913 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26156739 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 22835079 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 21076089 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 1988573 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 28656073 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 28656073 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study 28656073 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 19323926 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 16527696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14553957 — Surrogate Endpoint (SUR): Blood pressure
Study 10880809 — Predictive Biomarker (PRD): PLXNB1 mRNA
Genes: PLXNB1; KIAA0407; PLXN5; SEP
Study 23732754 — Predictive Biomarker (PRD): IL17F
Genes: IL-17F; ML-1; ML1
Study 17399824 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 14567559 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 14567559 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19